Therapeutic Potential of PPARγ Activation in Stroke
- PMID: 21909480
- PMCID: PMC2293414
- DOI: 10.1155/2008/461981
Therapeutic Potential of PPARγ Activation in Stroke
Abstract
Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of genes that promote these pathophysiological mechanisms can be an effective strategy to minimize the poststroke neuronal death. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors known to be upstream to many inflammatory and antioxidant genes. The goal of this review is to discuss the therapeutic potential and putative mechanisms of neuroprotection following PPAR activation after stroke.
Similar articles
-
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.Biochem Soc Trans. 2006 Dec;34(Pt 6):1341-6. doi: 10.1042/BST0341341. Biochem Soc Trans. 2006. PMID: 17073815 Review.
-
PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.Ther Adv Cardiovasc Dis. 2008 Jun;2(3):179-97. doi: 10.1177/1753944708090924. Ther Adv Cardiovasc Dis. 2008. PMID: 19124421 Review.
-
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.J Neurochem. 2007 Apr;101(1):41-56. doi: 10.1111/j.1471-4159.2006.04376.x. J Neurochem. 2007. PMID: 17394460
-
Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.FASEB J. 2006 Jun;20(8):1162-75. doi: 10.1096/fj.05-5007com. FASEB J. 2006. PMID: 16770015
-
Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.J Neurosci. 2003 Jul 16;23(15):6264-71. doi: 10.1523/JNEUROSCI.23-15-06264.2003. J Neurosci. 2003. PMID: 12867511 Free PMC article.
Cited by
-
Post-Ischaemic Immunological Response in the Brain: Targeting Microglia in Ischaemic Stroke Therapy.Brain Sci. 2020 Mar 11;10(3):159. doi: 10.3390/brainsci10030159. Brain Sci. 2020. PMID: 32168831 Free PMC article. Review.
-
Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.Neurochem Res. 2021 Nov;46(11):2800-2831. doi: 10.1007/s11064-021-03402-1. Epub 2021 Jul 20. Neurochem Res. 2021. PMID: 34282491 Review.
-
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.PPAR Res. 2012;2012:513865. doi: 10.1155/2012/513865. Epub 2011 Jun 9. PPAR Res. 2012. PMID: 21772838 Free PMC article.
-
Optimisation of a PC12 cell-based in vitro stroke model for screening neuroprotective agents.Sci Rep. 2021 Apr 14;11(1):8096. doi: 10.1038/s41598-021-87431-4. Sci Rep. 2021. PMID: 33854099 Free PMC article.
-
Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post-ischemic neuroinflammation.J Neurochem. 2024 Oct;168(10):3430-3448. doi: 10.1111/jnc.16055. Epub 2024 Jan 26. J Neurochem. 2024. PMID: 38279529 Review.
References
-
- Berger J, Moller DE. The mechanisms of action of PPARs. Annual Review of Medicine. 2002;53:409–435. - PubMed
-
- Moreno S, Farioli-Vecchioli S, Cerù MP. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience. 2004;123(1):131–145. - PubMed
-
- de Lera AR, Bourguet W, Altucci L, Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nature Reviews Drug Discovery. 2007;6(10):811–820. - PubMed
-
- Cunard R, Ricote M, DiCampli D, et al. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. Journal of Immunology. 2002;168(6):2795–2802. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources